DASGIP Adds to iPhone Offerings for Scientists
In keeping with the growing trend of iPhone applications for every conceivable convenience, DASGIP AG (Juelich, Germany), a provider of parallel bioreactor systems at benchtop scale, has launched an iPhone application for accessing bioprocesses online.
In keeping with the growing trend of iPhone applications for every conceivable convenience, DASGIP AG (Juelich, Germany), a provider of parallel bioreactor systems at benchtop scale, has launched an iPhone application for accessing bioprocesses online.
The company released its Remote Control Suite at the Biotechnica, which was held on October 6–8 in Hanover, Germany. With the Remote Control Suite, users can remotely observe and access running processes using an iPhone, iPod touch, or notebook computer.
Data security is ensured through the implementation of established IT security mechanisms. Remote modifications to all process values are tracked and logged in a central database for transparency and documentation.
By combining optional features such as an alarm function, scientists can receive around-the-clock notifications that enable them to react promptly when deviations in the planned process occur.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
